UB Paderborn / Katalog / Suche / in CDI

Successful Erlotinib Rechallenge After Erlotinib-Induced Interstitial Lung Disease

Journal of thoracic oncology, 2011-06, Vol.6 (6), p.1142-1143

2011

Volltextzugriff (PDF)

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Nature medicine, 2021-08, Vol.27 (8), p.1410-1418

2021

Volltextzugriff (PDF)

cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2267-2279

2016

Volltextzugriff (PDF)

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

Oncogene, 2023-06, Vol.42 (23), p.1926-1939

2023

Volltextzugriff (PDF)

Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Clinical cancer research, 2020-01, Vol.26 (2), p.439-449

2020

Volltextzugriff (PDF)

Mutation-associated fusion cancer genes in solid tumors

Molecular cancer therapeutics, 2009-06, Vol.8 (6), p.1399-1408

Kaye, Frederic J

2009

Volltextzugriff (PDF)

Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors

JNCI : Journal of the National Cancer Institute, 2015-08, Vol.107 (8), p.djv123

2015

Volltextzugriff (PDF)

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

Cells (Basel, Switzerland), 2024-03, Vol.13 (6), p.528

2024

Volltextzugriff (PDF)

Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

eLife, 2021-06, Vol.10

2021

Volltextzugriff (PDF)

Cetuximab‐associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck

Head & neck, 2019-04, Vol.41 (4), p.E55-E58

2019

Volltextzugriff (PDF)

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer: Lung cancer

Oncogene, 2002-10, Vol.21 (45), p.6908-6914

KAYE, Frederic J

2002

Volltextzugriff (PDF)

Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida

Cancers, 2023-10, Vol.15 (21), p.5226

2023

Volltextzugriff (PDF)

BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers

Journal of hematology and oncology, 2022-03, Vol.15 (1), p.23-23, Article 23

2022

Volltextzugriff (PDF)

PROTAC therapy as a new targeted therapy for lung cancer

Molecular therapy, 2023-03, Vol.31 (3), p.647-656

2023

Volltextzugriff (PDF)

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

JCI insight, 2021-04, Vol.6 (7)

2021

Volltextzugriff (PDF)

CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior

Genes chromosomes & cancer, 2007-07, Vol.46 (7), p.708-715

2007

Volltextzugriff (PDF)

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

Cell death discovery, 2023-01, Vol.9 (1), p.1-10, Article 1

2023

Volltextzugriff (PDF)

Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by Nicotine

Cancers, 2022-05, Vol.14 (9), p.2272

2022

Volltextzugriff (PDF)

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

Signal transduction and targeted therapy, 2021-01, Vol.6 (1), p.27-27, Article 27

2021

Volltextzugriff (PDF)

CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB–MYC involvement

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (32), p.E3260-E3268

2014

Volltextzugriff (PDF)

Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study

BMJ open, 2022-06, Vol.12 (6), p.e064142-e064142

2022

Volltextzugriff (PDF)

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)

Journal for immunotherapy of cancer, 2024-02, Vol.12 (2), p.e007883

2024

Volltextzugriff (PDF)

Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma

Oral oncology, 2013-11, Vol.49 (11), p.1059-1066

2013

Volltextzugriff (PDF)

DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer

Molecular cancer therapeutics, 2012-02, Vol.11 (2), p.370-382

2012

Volltextzugriff (PDF)

Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival

JCI insight, 2022-10, Vol.7 (19)

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Successful Erlotinib Rechallenge After Erlotinib-Induced Interstitial Lung Disease

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Mutation-associated fusion cancer genes in solid tumors

Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

Cetuximab‐associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer: Lung cancer

Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida

BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers

PROTAC therapy as a new targeted therapy for lung cancer

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by Nicotine

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB–MYC involvement

Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)

Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma

DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer

Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival

Suchergebnisse filtern